Dear reader,

You have just been vaccinated against COVID-19 with the vaccine COMIRNATY®.

This booklet will provide you with important information about COVID-19 vaccination as well as about the mode of action and safety of this vaccine.

The European Commission approved the COVID-19 mRNA vaccine COMIRNATY® from BioNTech on 12/21/2020 based on a prior recommendation for conditional approval by the European Medicines Agency (EMA). EMA is responsible for verifying the safety and effectiveness of drugs and vaccines. Since its approval, this vaccine has been available as an effective tool for fighting the coronavirus pandemic in Europe.

The approval procedure ran faster than usual by conducting some of the clinical trials at the same time and by submitting the data to EMA in an accelerated process while the studies were still ongoing.